Fig. 1From: Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemiaMutational spectrum of TET2, SRSF2, ASXL1 and SETBP1 stratified by FAB and WHO subtypes. (a) Mutations in SRSF2 and SETBP1 were more frequent in CMML-MP than CMML-MD. (b) There were no significant differences in mutation frequencies of these four genes between patients with CMML-1 vs. those with CMML-2Back to article page